top of page

Our Journey

Parents want to understand genetic causes of conditions affecting their children, so they can make informed decisions, improve treatment, and achieve better outcomes.

 

But too few have access to reliable, clinically meaningful genomic testing, clear and simple reports, follow-up care from trusted health professionals, and without delays from insurance approval, all at a cost that feels truly within reach. We’re here to change that.

Our team has spent over a decade helping doctors and families gain access to credible genetic testing.

We focus on offering genetic tests that are affordable, delivering results in a clear and meaningful way, and supporting families in using the information to take better care of their children and plan for the future.

Abstract Color Gradient

About Us

Modal Nova

stands for

Genome Modality Innovations

 

It reflects our commitment to advancing precision health through the integration of genomic and clinical modalities to improve diagnosis, treatment, and outcomes:

  • Improving diagnosis by correlating detailed understanding of patient’s symptoms with genomic findings

  • Delivering clinically meaningful variant interpretation, including situations with uncertain results (VUS)

  • Supporting care with actionable prognosis and surveillance recommendations

 

Our platform delivers clinically relevant reporting to primary care providers, with clear summaries and readings for parents and patients.

By bridging complex biological data with real-world clinical relevance, Nova aims to redefine how genomic medicine is delivered at scale.

Credible
Genetic Testing

CLIA-certified and CAP-accredited lab

Backed by
  • Clinical evidence
  • Peer-reviewed publications
  • Experienced clinical team 

We expect to launch our clinical testing paradigm in mid-2026. Contact us for more information.

bottom of page